Home
/ Bioven
/ Competitors

Bioven Competitors and Similar CompaniesClear all

Bioven's competitors and similar companies include Clovis Oncology, Tosk and Deciphera Pharmaceuticals.

	Bioven Bioven is a biopharmaceutical company dedicated to the development of treatments for cancer.	Clovis Oncology Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.	Tosk Tosk is a biopharmaceutical company that provides drug development solutions for cancer treatment.	Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
Founding Date	Founding Date 2002	Founding Date 2009	Founding Date 2008	Founding Date 2003
Type	Type Private	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Hamilton, BM HQ Kuala Lumpur, MY London, GB Sheffield, GB	Locations Boulder, US HQ Paris, FR München, DE Dublin, IE Milano, IT Madrid, ES Zürich, CH see more	Locations Mountain View, US HQ Sunnyvale, US	Locations Waltham, US HQ Lawrence, US
Employees	Employees N/A	Employees 4843% increase	Employees 109% decrease	Employees 35037% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 10.6 m	Valuation ($) N/A	Valuation ($) 2.2 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $148.8m (FY, 2021)	Revenue (est.) N/A	Revenue (est.) $163.4m (FY, 2023)
Net income	Net income N/A	Net income ($264.5m) (FY, 2021)	Net income N/A	Net income ($194.9m) (FY, 2023)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 357m	Total funding raised $ 8.6m	Total funding raised $ 714m